查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1304512

全球乳腺成像市場 - 2023-2030

Global Breast Imaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球乳腺成像市場規模在2022年達到42億美元，預計到2030年將實現79億美元的豐厚成長。預計在2023-2030年期間，全球乳腺成像市場將呈現8.4%的複合年成長率。技術的不斷進步和對新型產品投資的不斷成長推動了乳腺成像市場需求的發展趨勢。

乳腺成像市場包括確定產品存在的方式和應用。儘管乳腺癌在女性中更為常見，但男性也可能罹患乳腺癌。超音波、核成像MRI、乳腺X線攝影和熱成像是最常用於檢測乳腺癌和相關疾病的乳腺成像程序。新模式的推出和癌症患者的增加是推動全球乳腺成像市場發展的主要因素。

乳腺成像的市場範圍包括乳腺癌、乳腺疾病和其他應用，這增加了乳腺成像的市場佔有率。全球乳腺成像市場正在不斷擴大，其原因包括不斷增加的研究和開發，以及各國即將批准的新產品，這也為乳腺成像市場的成長創造了積極的前景。

市場動態

技術進步將推動乳腺成像市場的成長

乳腺X線照相術一直是放射科醫生乳腺癌成像工具的重要組成部分。自問世以來，它大大降低了乳腺癌的死亡率，是及時發現乳腺癌的重要篩查和診斷工具。

乳腺X線照相術與技術同步發展，從膠片到數位乳腺X線照相術，再到數位乳腺斷層合成術（DBT）。為了提高癌症檢出率、減少假陽性和改善預後，每一次發展都不斷解決放射醫師面臨的問題和患者的擔憂。

對比增強乳腺X線攝影（CEM）可能是乳腺成像的下一個發展方向，也是這一演變的結果。儘管該技術誕生於近十年前，但最近才開始引起人們的注意，因為新出現的研究強調了它相對於傳統輔助成像的優勢。

為了幫助檢測乳腺組織的異常，CEM使用與電腦斷層掃描（CT）技術相同的造影劑。造影劑通過血管流經乳腺組織，在病變形成和增大的地方積聚，採用與CT和磁共振成像（MRI）類似的物理成像概念。

不斷增加的研發和新型產品的推出為製造商創造了有利的機會

USPSTF建議年齡在50至74歲之間、有患乳腺癌平均風險的女性每兩年進行一次乳房X光檢查。 40至49歲的女性應與醫生或其他醫生討論何時開始以及多久進行一次乳房X光檢查。

例如，2022年5月，Therapixel - 一家創建基於人工智慧軟體的女性健康組織- 推出了MammoScreen 2D和3D，其最新版本可以使用以前的乳房X光照片進行分析。通過將其性能與先前的檢測進行比較，MammoScreen變得更加有效。

設備的局限性將阻礙市場成長。

在每兩年進行一次乳腺癌篩查的20年計劃中，並非每種乳腺癌都能被發現。在每兩年接受一次乳房X光檢查的1000名婦女中，有77名婦女在20年內會罹患乳腺癌。其中21人將在乳房X光檢查結果正常的情況下被診斷為癌症。

這種情況發生的條件是：所有乳腺癌患者都能存活；乳腺X光檢查未發現癌症；乳腺X光檢查時癌症尚未確定。據預測，在20年內每兩年接受一次乳房X光檢查的1000名婦女中，將有13人死於乳腺癌。乳房X光檢查也是一種X光檢查。在X光檢查過程中會釋放輻射，這一點與其他檢查一樣。

COVID-19影響分析

COVID-19疫情和全球封鎖對各行各業的企業財務健康產生了影響。因此，美國食品和藥物管理局(FDA)發布了COVID-19衛生緊急狀態期間的指導方針，其中包括協助申辦者和研究人員、確保試驗參與者安全、遵循良好臨床實踐(GCP)以及降低試驗完整性風險的一般注意事項。

俄烏戰爭影響分析

據估計，俄烏衝突對全球乳腺成像市場的影響較小，因為該地區的主要市場參與者較少。然而，原料進出口的影響預計在預測期內對全球乳腺成像市場的成長影響不大。

目錄

第一章研究方法和範圍

  • 研究方法
  • 研究目的和報告範圍

第2章：定義和概述

第3章：執行摘要

  • 按模式分類的摘要
  • 按應用分類
  • 按終端用戶分類
  • 按地區分類

第四章：動態

  • 影響因素
    • 驅動因素
      • 技術進步和新產品的不斷推出
      • 乳腺癌發病率上升
    • 限制因素
      • 設備的局限性
    • 機會
      • 研發和新產品上市的增加
    • 影響分析

第五章：行業分析

  • 波特五力分析法
  • 供應鏈分析
  • 定價分析
  • 法規分析

第六章：COVID-19分析

  • COVID-19分析
    • COVID-19之前的情況
    • COVID-19期間的情景
    • COVID-19之後的情景
  • COVID-19期間的定價動態
  • 供求關係
  • 大流行期間與市場相關的政府計劃
  • 製造商的戰略計劃
  • 結論

第七章：按模式分類

  • X光源
    • 乳腺攝影
    • 數位乳腺斷層攝影
    • 對比增強數位乳腺X線攝影
  • 超聲
    • 超聲
    • 對比增強超聲
    • 3D超聲
    • 彩色/功率多普勒
    • 組織彈性成像
  • 磁場
    • 磁共振成像
    • 磁共振波譜成像
    • 彌散加權成像
  • γ射線
    • 正電子發射電腦斷層掃描
    • 單光子發射電腦斷層掃描
  • 非電離輻射
    • 光學成像
    • 乳腺微波成像

第八章：按應用分類

  • 乳腺癌
  • 乳腺疾病
  • 其他應用

第九章：按最終用戶分類

  • 醫院
  • 影像診斷中心
  • 專科診所
  • 其他

第十章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 日本
    • 日本
      • 亞太其它地區
  • 中東和非洲
    • 主要地區動態

第十一章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併與收購分析

第十二章：公司簡介

  • GE Healthcare
    • 公司概況
    • 產品組合和描述
    • 財務概況
    • 主要發展
  • Siemens Healthcare GmbH
  • FUJIFILM Corporation
  • Koninklijke Philips NV
  • Hologic, Inc.
  • Canon Medical Systems Corporation
  • General Medical Merate SpA
  • Konica Minolta Healthcare Americas, Inc.
  • Metaltronica SpA
  • Planmed OY

第十三章：附錄

簡介目錄
Product Code: MI878

Market Overview

The Global Breast Imaging Market reached US$ 4.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 7.9 billion by 2030. The global breast imaging market is expected to exhibit a CAGR of 8.4% during the forecast period 2023-2030. The increasing technological advancements and the growing investments in novel products are driving up demand for breast imaging market trends.

The market for breast imaging includes modalities and applications that establish the existence of the products. Despite being more common in women, breast cancer can also affect men. Ultrasound, nuclear imaging MRI, mammography, and thermography are the breast imaging procedures most frequently used to detect breast cancer and associated diseases. The launch of new modalities and an increase in patients with cancer are the main factors propelling the global market for breast imaging.

The breast imaging market scope comprises application as breast cancer, breast diseases and others, which has increased the breast imaging market share. The global market for breast imaging is expanding as a result of factors including increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the breast imaging market growth.

Market Dynamics

Rising Technological Advancements will Drive the Growth of the Breast Imaging market

Mammography has existed as a crucial component of the radiologist's breast cancer imaging toolset. Since its creation, it has dramatically lowered the disease's mortality rates and is a crucial screening and diagnostic tool for the prompt identification of breast cancer.

Mammography has advanced alongside technology, going from film through digital mammography to digital breast tomosynthesis (DBT). To increase cancer detection rates, decrease false positives, and improve outcomes, each evolution has kept tackling the issues that radiologists face and the worries of patients.

Contrast-enhanced mammography (CEM), which may be the next development in breast imaging, is the result of this evolution. Although the technology was created almost 10 years ago, it has only lately begun to attract attention as a result of an emerging body of research that highlights its advantages over conventional supplementary imaging.

To help detect abnormalities in breast tissue, CEM uses the same contrast material as computed tomography (CT) technology. The contrast agent flows through the breast tissue via blood vessels and accumulates wherever lesions are forming and increasing, using similar physical imaging concepts as CT and magnetic resonance imaging (MRI).

Rising Research and Development and Novel Product Launches creates Lucrative Opportunities for Manufacturers

Women between the ages of 50 and 74 who have an average risk of developing breast cancer are advised by the USPSTF to undergo a mammogram once every two years. When to begin and how frequently to obtain a mammogram should be discussed with a doctor or another physician by women between the ages of 40 and 49.

For instance, in May 2022, Therapixel, an organization for women's health that creates AI-based software, unveiled MammoScreen 2D and 3D, its most recent version of which can use prior mammograms in analysis. By comparing its performance to earlier tests, MammoScreen becomes more effective.

Limitations Associated with Equipment Will Hamper the Growth of the Market.

Not every kind of breast cancer will be discovered with a 20-year breast cancer screening schedule of every two years. 77 women out of 1,000 who undergo a mammography every two years for 20 years will develop breast cancer. 21 of them will receive cancer diagnoses while having normal mammogram results.

This can happen if: every person with breast cancer will survive; The cancer was not detected on the mammogram; The cancer had not yet been established at the point of the mammography. It is predicted that 13 women out of 1,000 who receive mammograms every two years for 20 years will pass away from breast cancer. A mammography is an X-ray as well. Radiations are released during X-ray exams like with all others.

COVID-19 Impact Analysis

The COVID-19 epidemic and the worldwide lockdown have had an effect on the financial health of businesses in all industries. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the duration of the COVID-19 health emergency that include general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global breast imaging market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global breast imaging market growth over the forecast period.

Segment Analysis

The global breast imaging market is segmented based on modalities, application, end-user and region.

Breast Cancer From the Application Segment Accounts for 62.8% of the Market Share Owing to the High Incidence

Cancer is a condition when the body's cells proliferate out of control. Aside from skin cancer, breast cancer is the most common type of cancer in women in the US. Breast cancer remains the second-leading cause of cancer deaths amongst all women and is particularly prevalent among Hispanic women, despite a decline in the number of fatalities from the disease over time.

In the US, around 2,400 men and 264,000 women receive a breast cancer diagnosis each year. Each year, breast cancer claims the lives of 42,000 women and 500 men in the United States. Black women suffer from a higher breast cancer death rate than White women. Breast ultrasonography and mammography along with MRI can be helpful diagnostic tools.

According to recent studies, MRI can find some tiny breast tumors that mammography occasionally misses. Additionally, it can aid in the early detection of breast cancer in younger women with dense breast tissue and in those who have breast implants. Mammography might not be as useful in these circumstances. MRIs don't use radiation, so they can be used to screen people under 40 and increase the number of tests for people who are at elevated risk for breast cancer each year.

Geographical Analysis

North America Accounted for Approximately 39.6% of the Market Share Owing to the Strong Presence of Major Players and the Advancements in Breast Imaging

Manufacturers have chances to expand their operations in this region because of the rising demand for Breast Imaging for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of Breast Imaging, which has increased the demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for research and development of novel products.

The market will grow as new technology for research and development emerge. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. People are becoming more aware of novel products and therapies, leading to the expansion of the market in this region. These factors are responsible for the dominance of North America.

Competitive Landscape

The major global players in the breast imaging market include: GE Healthcare, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips NV, Hologic, Inc., Canon Medical Systems Corporation, Inc., General Medical Merate S.p.A., Konica Minolta Healthcare Americas, Inc., Metaltronica S.p.A and Planmed OY among others.

Why Purchase the Report?

  • To visualize the global breast imaging market segmentation based on modalities, applications, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of breast imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global breast imaging market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers / Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Modalities
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Technological Advancements and Novel Product Launches
      • 4.1.1.2. The Rising Incidence of Breast Cancer
    • 4.1.2. Restraints
      • 4.1.2.1. Limitations Associated with Equipment
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Research and Development and Novel Product Launches
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Modalities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 7.1.2. Market Attractiveness Index, By Modalities
  • 7.2. X-Ray Source *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Mammography
    • 7.2.4. Digital Breast Tomosynthesis
    • 7.2.5. Contrast-Enhanced Digital Mammography
  • 7.3. Ultrasound
    • 7.3.1. Sonography
    • 7.3.2. Contrast-Enhanced Ultrasound
    • 7.3.3. Three-Dimensional Ultrasound
    • 7.3.4. Color/Power Doppler
    • 7.3.5. Tissue Elasticity Imaging
  • 7.4. Magnetic Field
    • 7.4.1. Magnetic Resonance Imaging
    • 7.4.2. Magnetic Resonance Spectroscopy
    • 7.4.3. Diffusion-Weighted Imaging
  • 7.5. Gamma Radiation
    • 7.5.1. Positron Emission Tomography
    • 7.5.2. Single-Photon Emission Computed Tomography
  • 7.6. Non-Ionizing Radiation
    • 7.6.1. Optical Imaging
    • 7.6.2. Breast Microwave Imaging

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Breast Cancer *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Breast Disease
  • 8.4. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Imaging Centres
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Siemens Healthcare GmbH
  • 12.3. FUJIFILM Corporation
  • 12.4. Koninklijke Philips NV
  • 12.5. Hologic, Inc.
  • 12.6. Canon Medical Systems Corporation
  • 12.7. General Medical Merate S.p.A.
  • 12.8. Konica Minolta Healthcare Americas, Inc.
  • 12.9. Metaltronica S.p.A
  • 12.10. Planmed OY

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us